Utility of immunohistochemistry for α-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy

Human Pathology

Volumn 35, Issue 10, 2004, Pages 1272-1278

  Farinola, Maryam A ^a   Epstein, Jonathan I ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

methylacyl CoA racemase; AMACR; atrophic prostate cancer; benign atrophy; high molecular weight cytokeratin; HMWCK; PIN; prostatic intraepithelial neoplasia

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ANTIBODY; COENZYME A; PROPIONIC ACID; RACEMASE; UNCLASSIFIED DRUG;

ARTICLE; ATROPHIC PROSTATE CANCER; ATROPHY; BASAL CELL; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; ENZYME ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEEDLE BIOPSY; PROSTATE CANCER; PROTEIN EXPRESSION;

ADENOCARCINOMA; ATROPHY; BIOPSY, NEEDLE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 5444222899     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2004.06.015     Document Type: Article

References (13)

1. Cina S.J., Epstein J.I. Adenocarcinoma of the prostate with atrophic features. Am J Surg Pathol. 21:1997;289-295
2. Egan A.J.M., Lopez-Beltran A., Bostwick D.G. Prostatic adenocarcinoma with atrophic features Malignancy mimicking a benign process. Am J Surg Pathol. 21:1997;931-943
3. Jiang Z., Woda B.A., Rock K.L., et al. P504S A new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 25:2001;1397-1404
4. Xu J., Stolk J.A., Zhang X., et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 60:2000;1677-1682
5. Beach R., Gown A.M., de Peralta-Venturina M.N., et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol. 26:2002;1588-1596
6. Jiang Z., Wu C., Woda B.A., et al. P504S/α-methylacyl-CoA racemase A useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 26:2002;1169-1174
7. Luo J., Zha S., Gage W.R., et al. Alpha-methylacyl-CoA racemase A new molecular marker for prostate caner. Cancer Res. 62:2002;2220-2226
8. Magi-Galluzzi C., Luo J., Isaacs W.B., et al. Alpha-methylacyl-CoA racemase (AMACR) A variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Am J Surg Pathol. 27:2003;1128-1133
9. Rubin M.A., Zhou M., Dhanasekaran S.M., et al. Alpha-methylacyl-CoA racemase as a tissue biomarker for prostate cancer. JAMA. 287:2002;1662-1670
10. Zhou M., Chinnaiyan A.M., Kleer C.G., et al. Alpha-methylacyl-CoA racemase A novel tumor marker overexpressed in several human cancers and their precursor lesions. Am J Surg Pathol. 26:2002;926-931
11. Zhou M., Jiang Z., Epstein J.I. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase in foamy gland and pseudohyperplastic prostate cancer. Am J Surg Pathol. 27:2003;772-778
12. Epstein J.I., Yang X.J. Prostate Biopsy Interpretation. ed 3 :2002;Lippincott Williams & Wilkins, Philadelphia, PA
13. Parsons J.K., Gage W.R., Nelson W.G., et al. p63 protein expression is rare in prostate adenocarcinoma Implications for cancer diagnosis and carcinogenesis. Urology. 58:2001;619-624